PurpleStride is the number one way the Pancreatic Cancer Action Network (PanCan) raises money to fight pancreatic cancer on all fronts — through research, clinical initiatives, patient services, advocacy, and nationwide volunteer support. On Saturday, April 29, 2023, 60 PurpleStride events took place across the country to honor pancreatic cancer survivors, families, and caregivers, as … Continue reading PanCAN PurpleStride 04 -29 -2023
DER LAB BLUE RIBBON RUN 2023
Congratulations to the running RAScals for being the third fastest team at the Blue Ribbon Run this weekend! We have some marathon heroes to be proud of: Coming in first place for the Running RAScals and first place in his age group was Clint Stalnecker. Additionally, big congrats to first time individual medalist Kristė Drizyte-Miller, who placed third … Continue reading DER LAB BLUE RIBBON RUN 2023
Nate Diehl Awarded at Postdoc Day
Der Lab member, Nate Diehl, recently attended the 45th Annual Postdoc Faculty Research Day-- a symposium run primarily by the ITCMS Postdoc trainees and welcome to all of UNC Lineberger trainees and graduate students. Nate was awarded for Best Graduate Student Poster. He presented on Life without KRAS: profiling the KRAS-dependent kinome to identify novel therapeutic vulnerabilities … Continue reading Nate Diehl Awarded at Postdoc Day
Der Lab Publishes in Cancer Discovery
UNC Lineberger’s Channing Der, PhD, and Antje Schaefer, PhD. UNC UNC Lineberger's Channing Der, Ph.D. Sarah Graham Kenan Distinguished Professor in the UNC School of Medicine Department of Pharmacology was the co-corresponding author of a paper published in Cancer Discovery. Antje Schaefer, Ph.D., research assistant professor in the UNC School of Medicine Department of Pharmacology, … Continue reading Der Lab Publishes in Cancer Discovery
Der Lab Goes Purple for Pancreatic Awareness
For the month of November, the Der and Cox labs have gone purely purple. The dress code is inspired by the official pancreatic cancer ribbon and is worn all month to bring awareness to pancreatic cancer. See ABC 11's interview with Dr. Jen Jen Yeh and Dr. Kirsten Bryant here. Photos courtesy of the UNC … Continue reading Der Lab Goes Purple for Pancreatic Awareness
Researchers find KRAS gene mutation differences have implications for pancreatic cancer treatment
A new study from University of North Carolina Lineberger Comprehensive Cancer Center researchers reveals important findings about how a common genetic mutation in pancreatic cancer works to drive tumor growth. In the journal Cancer Discovery, researchers led by UNC Lineberger’s Channing Der, PhD, and Aaron Hobbs, PhD, reported details of the role of a particular mutation … Continue reading Researchers find KRAS gene mutation differences have implications for pancreatic cancer treatment
Channing Der Quoted by Bloomberg
Right DirectionThe findings follow data this summer that showed half of those treated with Amgen’s drug at a wide range of doses responded. The latest results more than doubled the number of patients treated with the highest dose and tracked them for three more months. It’s too early to know how long the benefits will last and … Continue reading Channing Der Quoted by Bloomberg
Kirsten Bryant Accepts Pagano Award
September 4, 2019 Congratulations to Kirsten Bryant, Ph.D., for her acceptance of the Joseph S. Pagano Award! This award recognizes outstanding work by the Lineberger’s postdoctoral research associates. We are proud of Kirsten's accomplishments. Read more about Kirsten's award ceremony.
Der Lab Blue Ribbon Tour 2019
August 5, 2019 Today, the Der and Cox labs were visited by the Blue Ribbon group of Wilmington, NC. The Blue Ribbon Run raises money for the Julie M. Brown and Christina M. Gianoplus Fund for Colon Cancer Research from Wilmington, NC. Members of the group included Ana Boudreau, event founder, and Sarah Powell, a … Continue reading Der Lab Blue Ribbon Tour 2019
Congratulations, Nate Diehl and Jenny Klomp!
Nate Diehl was awarded an NCI F30 Individual Predoctoral MD/Ph.D. fellowship entitled “Validation of WEE1 kinase as a clinical target in KRAS-mutant pancreatic cancer”. Jenny Klomp, Ph.D., was awarded an NCI F32 Individual Postdoctoral fellowship entitled “Defining the roles of the ERK MAPK in driving KRAS-mutant pancreatic cancer growth”. Congratulations to you both!
Der Lab 